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Angiotensin II stimulation of prostaglandin E2 and 6-keto-Fia
formation by isolated human glomeruli
ROLF A. K. STAHL, MARGIT PAivIcINI, and PETER SCHOLLMEYER
Department of Medicine, University of Freiburg, Freiburg, Federal Republic of Germany
Angiotensin H stimulation of prostaglandin E2 and 6-keto-F1 forma-
tion by isolated human glomeruli. The intrinsic in vitro production of
prostaglandins (PGs) E2, F2,,, 6-keto-F1,,, and thromboxane B2 (TxB2)
and the conversion of exogenous substrate to PGs and TxB2 by iso-
lated human glomeruli was demonstrated. 6-keto-PGF1,, was the major
product. This was observed under basal conditions and following in-
cubation with exogenous substrate. Indomethacin (Indo; i0 M) in-
hibited the conversion of arachidonic acid to PGs and the release of
[l-'4C]-labeled products from human glomeruli by about 80%. The ad-
dition of angiotensin II (All) to the isolated glomeruli produced, under
basal conditions, an almost selective stimulation of 6-keto-PGF1,,. Fol-
lowing the prelabeling of glomeruli with l-'4C-arachidonic acid, the in-
crease of glomerular PG formation after All was added was also only
significant for 6-keto PGF1,,. When glomeruli were preincubated with
large amounts of non-radiolabeled substrate, All stimulated PGE2 and
6-keto-PGF1,, formation significantly. The data demonstrate PG forma-
tion in isolated human glomeruli and show an interaction between
All and the prostaglandin system in this tissue. This interrelationship
might have physiologic consequences in the regulation of glomerular
hemodynamics.
L'angiotensine H stimule Ia formation de prostaglandine E2 et de 6-
céto-F1,, par des glomerules humains isolés. La production intrinseque
in vitro de prostaglandines (PGs) E2, F2,,, 6-cèto-F1,,, et de thrombox-
ane B2 (TxB2) et la conversion de substrat exogene en PGs et TxB2 par
des glomérules humains isolés ont été démontrées. La 6-céto-PGF1,,
était le produit principal des glomérules humains isolés in vitro. Cela a
été observe dans les conditions basales et apres incubation avec du
substrat exogène. L'Indométhacine (Indo; l0- M) inhibait Ia conver-
sion de l'acide arachidonique en PGs et le relargage de produits
marques au (l-'4C) par les glomérules humains d'environ 80%.
L'addition d'angiotensine II (All) aux glomerules isolés a produit dans
les conditions basales une stimulation presque selective de 6-céto-
PGF1,. Après marquage prealable des glomérules avec de l'acide ar-
achidonique marqué au (l-14C), l'augmentation de la formation
glomerulaire de PG après All était également seulement significative
pour Ia 6-céto-PGF1,,. Lorsque les glomerules étaient préalablement in-
cubes avec de grandes quantites de substrat non radioactif, I'AII sti-
mulait significativement Ia formation de PGE2 et de 6-céto-PGF1,. Ces
données démontrent la formation de PG dans des glomerules humains
isolés et indiquent une interaction entre l'AII et le système des pros-
taglandines dans cc tissu. Cette interrelation pourrait avoir des
consequences physiologiques dans la regulation de l'hemodynamique
glomérulaire.
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The identification of the glomerulus as a major site of cyclo-
oxygenase activity [1] was followed by the demonstration of
prostaglandin and thromboxane synthesis in isolated rat
glomeruli [2—4]. Glomerular prostaglandins participate in the
mechanisms of renin release in the rat [5] and the regulation of
glomerular ultrafiltration [6]. In situations with reduced renal
perfusion, associated with elevated angiotensin 11 (All) con-
centrations, vasodilatory prostaglandins countervene the ef-
fects of All to maintain renal blood flow and glomerular filtra-
tion rate (GFR) [7]. Furthermore, changes in glomerular func-
tion are followed by alterations of glomerular prostaglandin and
thromboxane formation [8, 9].
A similar role of vasodilatory PGs might exist in humans.
Evidence for such a suggestion is derived from clinical stud-
ies. In patients with reduced circulating volumes, the inhibi-
tion of the renal prostaglandins is followed by a sudden de-
crease of GFR [10, 11]. To test whether alterations in human
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glomerular PG formation in response to All could participate
in the regulation of glomerular hemodynamics, we evaluated
PG and TxB2 formation by isolated human glomeruli.
Methods
Isolation of glomeruli. Human renal tissue was derived from
9 patients who had undergone nephrectomy because of hyper-
nephroma. Only tumor-free renal tissue was investigated. No
glomerular or interstitial diseases were present. The glomeruli
were isolated within 2 hours after nephrectomy.
Glomeruli were prepared by a sieving technique [12] modi-
fied as described in the following manner: All steps were done
in ice-cold Krebs-Ringer buffer. The renal cortical tissue was
minced and pushed through a stainless-steel sieve with an
opening of 250 tim. The material under the sieve was collected
and sieved again, using a sieve with an opening of 210 m. Af-
ter several washings, the tissue on the sieve was collected and
resuspended in 10 to 15 ml of buffer. Then, the material was
centrifuged at x 125g for 60 seconds, and the supernatant was
decanted. This procedure was repeated up to five times. The
pellet consisted of glomeruli that were free of capsules, af-
ferent and efferent arterioles. Purity of glomeruli after each iso-
lation procedure was controlled by light microscopy. The in-
vestigated preparations consisted of 95% or more of glomeruli.
Superfusion procedure. Isolated human glomeruli were
transferred on a millipore filter (pore size, 0.8 m; Sartorius,
Gottingen, FRG), which was placed in a glass chamber held in
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a water bath at 37° C. The incubation chambers and the length
of the tubings of all chambers were identical. The loss of ara-
chidonic acid (AA) to the tubular walls and the chamber was
about 25% in a 20-minute superfusion period (estimated by the
superfusion with [l-'4C]-arachidonic acid). Prewarmed Krebs-
Ringer-Buffer (KRB) served as superfusion medium. Perfusate
(4 ml) was used in a closed system at a superfusion rate of 32
ml/min under air conditions. At the end of each superfusion pe-
nod, the perfusate was collected quantitatively on ice and fro-
zen at —20° C until the time of its analysis for PGs and TxB2.
Four incubations were run concurrently. At the end of each ex-
periment, glomeruli were collected quantitatively from the fil-
ter for determination of glomerular protein content performed
according to the method of Lowry et al [13].
Protocol 1. Similar amounts of glomeruli (400 to 500 g of
glomerular protein) were pre-superfused for 20 minutes. Three
experimental periods followed, each of 20 minutes' duration.
The perfusates in periods 1 and 2 contained KRB, KRB plus
indomethacin (l0 M) (MSD, MUnchen, FRG), or KRB plus
All (only period 1) (10— M, 10—8 M, 10—6 M) (Ciba Geigy,
Basel, Switzerland). In period 3, arachidonic acid (l0 M)
(Sigma Chemicals, Munchen, FRG) was added to the perfus-
ates. In periods 2 and 3, no All was present. Additional experi-
ments were run with arachidonic acid plus indomethacin (N =
6). PGs and TxB2 in the perfusates of periods 1 and 2 were de-
termined by direct radioimmunoas say (RIA) in the unex-
tracted medium. Formation of cyclooxygenase products in pe-
riod 3 was determined by RIA after extraction of the medium
and chromatographic separation of the arachidonic acid
metabolites.
Protocol 2. Almost identical amounts of glomeruli (511 4
glomeruli per incubation chamber) were pre-superfused for 60
minutes with KRB to deplete substrate pools. A 150-minute
superfusion period followed where 2.5 Ci of [l-'4C]-arachi-
donic acid (40 to 60 mCi/mmole) (New England Nuclear, Drei-
eich, FRG) was used as substrate for the labeling of glomer-
ular cell membrane stores. Two 5-minute incubations followed
to wash the system and to remove the unincorporated sub-
strate. Then a 10-minute experimental period was performed
where either KRB (N = 6) or KRB plus All (10—8 M) (N = 6)
was used as perfusate.
Protocol 3. For this experiment, glomeruli were isolated
from one kidney. They were incubated in a plastic tube in 2 ml
of KRB, which contained 100 g of arachidonic acid per milli-
liter. Incubation was carried out at 20° C for 6 hours. Then, the
glomeruli were divided in similar amounts (300 to 400 g of
glomerular protein), transferred on filters, and two 5-minute
pre-superfusion periods run to wash the tissue. Then, a 20-
minute experimental period was performed in which either
KRB (N = 6) or KRB plus All (10-8 M; N = 6) was used as
perfusate. PGs and TxB2 were determined by direct radio.
immunoassay in the perfusates; they are expressed in pico-
grams per milligram of glomerular protein per minute.
Extraction and chromato graphic separation. Fractions of
the perfusates were acidified to a pH of 3.5 with hydrochloric
acid and extracted three times with 5 ml of ethyl acetate. Prior
to acidification, a tritiated substance (3H-TxB2, 3H-6-keto-
PGF1, 3HPGF2a, 3H-PGE2, or 3H-A.A.; 400 to 500 cpm) was
added to account for recovery. The extracts were dried under
air stream, redissolved in 0.2 ml of methanol, and transferred
to a silica-gel-TLC plate (5721-Merck, Darmstadt, FRG) to-
gether with PG, TxB2, and arachidonic acid standards. The
plates were developed three times, with ethyl acetate, isooc-
tane, acetic acid, and water (10:5:2:10) as the solvent system.
Standards were visualized by iodine vapor and 18 zones (each,
1 cm) were scraped off the plates. The material was eluted
twice with methanol (2 ml), dried, and redissolved in phos-
phate buffer. Then, RIAs were performed, or when [l-'4C]-ara-
chidonic acid was used, the extracts were counted in the '4C
and H channels of a liquid scintillation counter. To allow com-
parison among the 1-carbon 14 products and the quantities de-
termined by RIA, the results were corrected for recovery of tri-
tiated standards. Recovery was very consistent, between 37
and 44%.
Radioimmunoassay. Quantitative determination of pros-
taglandins and thromboxane B2 was performed by radio-
immunoassay. All samples that had exogenous arachidonic
acid added to the incubation media were extracted and sepa-
rated on TLC prior to RIA. Radiolabeled products were de-
rived from New England Nuclear, Dreieich, FRG. PG and
TxB2 standards were purchased from Upjohn Company,
Kalamazoo, Ml, USA. Antisera for PGE2, PGF2, and TxB2
were from Institute Pasteur, Paris, France. The 6-keto-PGF1
antiserum was from Paesel GmbH, Frankfurt, FRG.
Assays for PGE2 and PGF2a were performed according to
Dray and Charbonnel [141. RIAs for TxB2 and 6-keto-PGF1
were carried out by a similar technique. The cross-reactivities
for the antisera are as follows: PGE2 antiserum to PGF2a,
0.06%; to TxB2, 0.01%; to arachidonic acid and 6-keto-PGF1a,
not tested. The 6-keto-PGF1a antiserum to PGF2. is 2.3%; to
PGE2, 0.06%; to arachidonic acid, 0.009%; to TxB2, 0.01%. (A
fifty percent displacement was achieved with 82 4 pg of 6-
keto PGF1.) The TxB2 antiserum to 6-keto PGF1. was 0.01%;
to arachidonic acid, 0.0015%; to PGE2, 0,1%. The PGF2. an-
tiserum to TxB2 was 0.3%; to PGE2, 0.1%; to 6-keto PGF1,
0.7%.
The data for PG and TxB2 formation by isolated glomeruli
are given as the means SEM and expressed in picograms per
milligram of glomerular protein per minute of incubation time,
or as counts per minute per 500 glomeruli. Statistical analysis
was performed with Student's t test. P values < 0.05 were con-
sidered significant.
Results
Table I summarizes the profile of radioimmunoassayable
PGs and TxB2 produced by isolated human glomeruli. Under
basal conditions (periods 1 and 2) in the absence of exogenous
substrate, the relative abundance of PGs and TxB2 was 6-keto-
PGF1> PGE2 PGF2a > TxB2. Except for PGE2 in period
I, indomethacin inhibited PG and TxB2 formation to values
that were not detectable with our assays. Following the incu-
bation with arachidonic acid (period 3), formation of all PGs
and TxB2 increased significantly (P values for all, < 0.001). 6-
keto-PGF1 was still the major product by isolated human
glomeruli. There was more than 80% inhibition of cyclooxy-
genase products, when indomethacin was added.
A representative radiochromatogram of human glomeruli pre-
labeled with [l-'4C]-arachidonic acid is shown in Fig. 1. Cor-
responding to the arachidonic acid, PG, and TxB2 standards,
peaks of carbon 14 activity were detected. Corrected for re-
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Period 3
Period I Period 2 (40 to 60
(0 to 20 (20 to 40 minutes
minutes) minutes) + i0 M AA)
PGE2, pg/mg/mm 58.4 12.7 22.2 7.2 164.2 16*
+ Indomethacin 12.7 2.7 n.d. 35.2 8.1**
PGF, pg/mg/mm 35.3 9.2 14.7 1.4 229 41.4*
+ Indomethacin nd. nd. 48 11.2**
6-keto-PGF
pg/mg/mm 100.4 19.6 100.6 9.9 696 67.2*
+ Indomethacin nd. n.d. 64 12.4**
TxB2,pg/mglmin 8.9 3.1 n.d. 35.4 4.2*
+ Indomethacin n.d. n.d. n.d.**
4 6 8 10 12 14 16
Distance from origin, cm
Fig. 1. Thin-layer chromatogram of [1-'4C1-products released by iso-
lated human glomeruli in vitro in the absence (•—•) and presence(A—A) of indomethacin. The peaks correspond to the standards of
6-keto PGF1a, PGF2a, TxB2, PGE2, and arachidonic acid (AA).
covery, the activity corresponding to the 6-keto PGF1,. stand-
ard was greatest, followed by high amounts of PGF2. When
indomethacin was present, the accumulation of carbon 14 ac-
tivity was markedly reduced. Between PGE2 and arachidonic
acid, there was a peak of unidentified activity almost not in-
hibited by indomethacin. These results were confirmed by five
additional experiments in which tissue of different kidneys was
used.
The effect of increasing the concentration of All on basal hu-
man glomerular PG formation in the absence of exogenous sub-
strate (period 1) is summarized in Table 2. Except for 6-keto
PGF1 at the 10-8 M and 106 M concentration, All did not af-
fect in vitro glomerular PG and TxB2 production significantly.
The 6-keto PGF1,, production, however, was stimulated by
over 90% at the 10_8 M All concentration.
Table 3 demonstrates the effect of All on the release of car-
bon 14 products by isolated human glomeruli. There was a sig-
nificant increase of radiolabeled products, corresponding to the
6-keto-PGF1 standard. Formation of TxB2, PGF2a), PGE2, and
arachidonic acid showed a tendency to increase; however, the
alterations were not significant.
The effect of All on radioimmunoassayable PG and TxB2
production by glomeruli that were preincubated with large
amounts of arachidonic acid is summarized in Table 4. Angio-
ten sin II stimulated in this preparation the formation of glomer-
ular PGE2 and 6-keto PGF1a). No effect was observed for
PGF2 and TxB2.
Discussion
The present data demonstrate the formation of prostaglan-
din E2, F2a), 6-keto-F1a), and thromboxane B2 by isolated hu-
man glomeruli. The production of PGs and TxB2 represents de
novo synthesis, because indomethacin reduced their in vitro
formation. The major cyclooxygenase product released by iso-
lated human glomeruli was 6-keto-prostaglandin This was
observed under basal conditions and following the administra-
tion of exogenous substrate. After prelabeling the membrane
pools with carbon-14 labeled arachidonic acid, the release of
carbon 14 corresponding to the 6-keto PGF1. standard was also
greatest. The release of carbon 14 from human glomeruli cor-
responding to the PG standards was reduced, when the tissue
was incubated with indomethacin. This confirms the RIA data.
There was a peak of carbon 14 activity between PGE2 and ara-
chidonic acid, which was almost not inhibited by indometh-
acm. We did not identify these substances, but based on ob-
servations by others, they could be products of the lipooxygen-
ase [15].
There are differences in the patterns of relative abundance of
PGs when we compare our data with those of a recent publi-
cation by Sraer et al [16]. They also found 6-keto-PGF1,, to be
the major product by isolated human glomeruli in vitro. In their
study, however, TxB2 formation was much greater than PGE2
and PGF2 production. These differences between the studies
might depend on the different methodologies of in vitro incu-
bation and on the different handling of the renal tissue prior to
the isolation procedure. Thus, we believe that the data of both
studies, in terms of the relative abundance of PGs, are not nec-
essarily comparable.
In addition to the finding of PG formation in isolated human
glomeruli, we observed a stimulatory effect of All on human
glomeruli in vitro. This action by All under basal conditions
was exclusively significant for 6-keto-PGF1a) production. The
reduced effect of the 10-6 M concentration might depend on the
ability of All in "high" amounts not only to stimulate release
of substrate by activation of phospholipase [17] but also to in-
crease incorporation of arachidonic acid in the membrane
pools, as suggested by Schlöndorff et al in the rat glomerulus
[181. After the prelabeling membrane pools with carbon 14 sub-
strate, All showed the same effect. Only 6-keto-PGF1 produc-
tion increased significantly. Although there was a tendency for
PGE2, PGF2a), and arachidonic acid formation to increase, the
changes did not reach significance. When glomeruli, however,
Table 1. Prostaglandin E2, F, 6-keto-F, and thromboxane B2




a Values are the means SEM (N = 4); nd. means not detectable,
Periods 1 and 2 are basal conditions; period 3, following incubation with
arachidonic acid (AA). PG and TxB2 production increased significantly
in period 3 (P < 0.001). Their production decreased significantly (**P
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Table 2. Effect of angiotensin 11 (All) on in vitro glomerular prostaglandins (PG) and thromboxane B2 (TxB2) formationa
Control lObo M All 10 M All 10 M All
PGE2, pg/mg/mm 58.4 25.1 46.2 17 87 28 54.2 7.6
6-keto-PGF1a, pg/mg/mm 100.4 19 128 6.1 195 12* 178 21**
TxB2, pg/mg/mm 8.9 3.2 10.1 3.2 11.3 4.1 14.3 3.6
PGF,, pg/mg/mm 45.3 9.4 52.6 17.2 51.5 12 62.5 21
a Values are the means SEM. The data were obtained during superfusion period 1 in the absence of exogenous substrate. PGs and TxB2 were
determined by direct RIA of the incubation medium. Statistical significance is denoted by asterisks: * < 0.001, J2 < 0.025.











Control (N = 6) 1405 106 3193 328 665 75 3824 294 22706 4280
All (N = 6) 2067 460 3741 1039 897 158 7329 1109* 28213 3286
a Values are the means SEM. Statistical significance is denoted by an asterisk: * < 0.001.
Control(N=6) 137± 8.4
All
Table 4. Effect of 108 as angiotensin I! (All) on human glomerular
prostaglandins (PG) and thromboxane 82 (TxB2) formation after




pg/mg/mm pg/mg/mm pg/mg/mm pg/mg/mm
98.2 6.4 36.4 3.8 298 41
(N 6) 228 22.3* 116.4 11.8 32.7 5.6 604 78**
"Values are the means SCM. PGs and TxB2 were determined by
direct RIA of the unextracted media. Statistical significance is denoted
by asterisks: *J) < 0.05, < 0.001.
were preincubated with large amounts of exogenous substrate,
the formation of 6-keto-PGF1a and PGE2 was significantly
stimulated by All. This observation suggests that under basal
conditions and following the prelabeling of substrate pools, the
effect of All on PGE2 formation was masked (even though
there was always a tendency for stimulation). For the basal
conditions, this might depend on a depletion of substrate pools,
probably induced by an unspecific stimulation during the iso-
lation procedure. In the presence of radiolabeled substrate, an
incomplete repletion might be proposed. The positive effect of
All on 6-keto-PGF1a, which was observed under all condi-
tions, might depend on the fact that PGI2 is the major product
of isolated glomeruli and is therefore the primary product aft-
erstimulation.
A selective stimulatory effect of Al! on 6-keto PGF1,. forma-
tion was found in rat glomeruli [18]. Stollenwerk-Petrulis,
Aikawa, and Dunn [15], Scharschmidt and Dunn [19] and Sra-
er et al [20) found All to increase, selectively, PGE2 in rat
glomerular epithelial [18] and mesangial [19] cells in culture,
and PGE2 and PGF2a in the epithelial and mesangial cells, re-
spectively, of rat glomeruli [20]. As already proposed by oth-
ers [15, 18], we would also suggest from our observation that
the almost selective stimulation of PG!2 (determined as 6-keto
PGF1a) and PGE2 in human glomeruli by All represents a spe-
cific response.
This proposal is based on the observations by Needleman et
al [21], who found that the effect of All to stimulate PGs is
probably the result of the activation of a peptide-linked recep-
tor at the cell membrane that activates arachidonic acid, which,
by a specific cyclooxygenase, is converted to PGs. Even
though this has been proven only for rabbit kidney tissue, it
seems to be a plausible explanation for our observation in hu-
man glomeruli. The specificity of a selective response of the PG
system to All is also supported by recent data obtained by
Chansel et al [22], who found a very high rate of All bindings
sites at the isolated human glomerulus.
A functional role for the high PGI2 formation under basal
conditions and in response to All might be discussed, based on
a recent observation by Scharschmidt, Dunn, and Norris et al
[23]. These investigators demonstrated that the threshold for
All to reduce glomerular surface area is increased after the in-
cubation of the glomeruli with arachidonic acid. Because PGI2
is the major product of human glomeruli and is a potent vasodi-
lator of most vascular tissue [241, it might be possible that in-
creased PG!2 and PGE2 formation in the glomerulus opposes
the constrictor effects of All in the glomerulus [23].
In summary, we have shown (1) that prostaglandins and
thromboxane B2 are produced in isolated human glomeruli in
vitro, (2) that 6-keto-PGF1a is the major product of the iso-
lated glomeruli, and (3) that angiotensin II stimulates the for-
mation of prostaglandin E2 and 6-keto F1,.
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